Document is current
Any future updates will be listed below
-
Authors
Pyne, Michael E.
Kevvai, Kaspar https://orcid.org/0000-0001-5074-4030
Grewal, Parbir S. https://orcid.org/0000-0002-9364-8062
Narcross, Lauren
Choi, Brian https://orcid.org/0000-0003-2976-8577
Bourgeois, Leanne
Dueber, John E. https://orcid.org/0000-0001-8404-7153
Martin, Vincent J. J. https://orcid.org/0000-0001-7511-115X
- License Information
-
More Information
Article History
Received: 20 May 2020
Accepted: 17 June 2020
First Online: 3 July 2020
Competing interests
: The research reported in this paper was financially supported by River Stone Biotech ApS and two patents had been filed relating to the inactivation of tyrosol-forming (U.S. Provisional Patent Application No. 62/688,989) and 4-HPAC-forming (U.S. Provisional Patent Application No. 62/943,203) enzymes in the context of high-titer production of benzylisoquinoline alkaloids.
